NDC 0409-2305-55 - Midazolam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-2305
- Requested NDC
- 0409-2305-55
- Package NDCs from labels
- 0409-2305-16, 0409-2305-17, 0409-2305-04, 0409-2305-05, 0409-2305-55, 0409-2305-50
- Manufacturer
- Hospira, Inc. | Pfizer Healthcare India Private Limited
- Effective date
- 2026-08-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Midazolam - Hospira, Inc. | Pfizer Healthcare India Private Limited | Hospira, Inc. | Pfizer Healthcare India Private Limited | 2026-08-12 | HUMAN PRESCRIPTION DRUG LABEL |
| MIDAZOLAM - Hospira, Inc. | Pfizer Healthcare India Private Limited | Hospira, Inc. | Pfizer Healthcare India Private Limited | 2026-08-12 | HUMAN PRESCRIPTION DRUG LABEL |
| Midazolam - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-06-10 | HUMAN PRESCRIPTION DRUG LABEL |
| MIDAZOLAM - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2020-03-11 | HUMAN PRESCRIPTION DRUG LABEL |
| MIDAZOLAM HYDROCHLORIDE - Cardinal Health | Cardinal Health | 2019-06-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-2305-04 | Midazolam | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 5 | 34 | |
| 0409-2305-05 | Midazolam | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 34 | |
| 0409-2305-16 | Midazolam | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 34 | |
| 0409-2305-17 | Midazolam | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 34 | |
| 0409-2305-50 | MIDAZOLAM | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 18 | |
| 0409-2305-55 | MIDAZOLAM | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 5 | 18 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0409-2305 | MIDAZOLAM HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 31 | Current NDC, Legacy NDC, 4 package rows | 20250129_1abda8b8-48a8-4995-af86-39220d1aa240.zip |
| 0409-2305 | MIDAZOLAM HYDROCHLORIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 16 | Current NDC, Legacy NDC, 2 package rows | 20241201_b95415fa-17c2-42ab-a6b0-e628d01c94ed.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-2305-02 | ML - Milliliter | 0409-2305 | 98253dc2-cea7-4525-a3ba-8501b7f6c5e8 | 1 | 2012-07-24 |
| 0409-2305-04 | ML - Milliliter | 0409-2305 | de4bce48-0fc0-4223-a261-039c00a587b6 | 1 | 2020-02-13 |
| 0409-2305-05 | ML - Milliliter | 0409-2305 | 12e3eb93-2779-475c-8b8e-bc237591d2ba | 1 | 2012-07-24 |
| 0409-2305-16 | ML - Milliliter | 0409-2305 | 5e7e3c5f-a976-4520-a459-62f2ff11d864 | 1 | 2020-02-13 |
| 0409-2305-17 | ML - Milliliter | 0409-2305 | f88f3d1d-297c-4e57-870c-977b5c1ce9d5 | 1 | 2012-07-24 |
| 0409-2305-21 | ML - Milliliter | 0409-2305 | c87b68e3-5cb3-470e-bb01-4524645ba74b | 1 | 2012-07-24 |
| 0409-2305-49 | ML - Milliliter | 0409-2305 | fab609b7-2497-4d17-b98f-d436db9dab6c | 1 | 2012-07-24 |
| 0409-2305-50 | ML - Milliliter | 0409-2305 | a54d35d2-1118-4ee2-93bf-46a2179969e0 | 1 | 2012-07-24 |
| 0409-2305-55 | ML - Milliliter | 0409-2305 | 419c9af9-b6c3-42b3-bbe5-5d5ae95028ca | 1 | 2020-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Midazolam Hydrochloride | MIDAZOLAM HYDROCHLORIDE | A-S Medication Solutions | 5e85e477-d483-4345-8d7b-d7dcdc3e0652 | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | W7TTW573JJ |
| Midazolam Hydrochloride | MIDAZOLAM HYDROCHLORIDE | American Health Packaging | fc93242b-0abf-466a-8413-8a365620ee75 | 2026-07-28 | Boxed warning, Warnings, Adverse reactions | W7TTW573JJ |
| Delflex | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | a98facd6-9daa-4d37-8209-63a0599dbfaa | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | 9a1220fb-6853-45ae-838c-10d8596e1af7 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | af5cdf1a-19f4-11e2-892e-0800200c9a66 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 19daf830-7270-4661-81b1-ded38f867f28 | 2026-07-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Whisidom Saline Solution | SODIUM CHLORIDE 0.9% SALINE SOLUTION | Jiangxi Yudexi Pharmaceutical Co., LTD | 4e4e4169-2a14-3466-e063-6394a90a081b | 2026-07-20 | Warnings | 451W47IQ8X |
| Saline | NASAL | BEST CHOICE (VALU MERCHANDISERS COMPANY) | 71485e82-bf54-4b8b-8dd2-2a0761534520 | 2026-07-17 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-07-15 | Warnings, Adverse reactions | 451W47IQ8X |
| WHWSWB 0.9% SALINE | SODIUM CHLORIDE | Yiwu Huanshu E-commerce Co., Ltd | 5082b773-79b2-2501-e063-6394a90a170f | 2026-07-11 | Warnings | 451W47IQ8X |
| SALINE NASAL | SODIUM CHLORIDE | ALAINA HEALTHCARE PRIVATE LIMITED | ed30a7f9-7132-42da-9bed-63a9b1c80ab2 | 2026-07-07 | Warnings | 451W47IQ8X |
| The Cell Salt Co. Daily Blend 12 in 1 | CALC FLUOR, CALC PHOS, CALC SULPH, FERRUM PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT MUR, NAT PHOS, NAT SULPH, SILICEA | The Cell Salt Company LLC | 55826f59-acf4-7370-e063-6394a90afed7 | 2026-07-01 | Warnings | 451W47IQ8X |
| NebuClear MD Saline | NEBUCLEAR MD SALINE | Blue Echo Care LLC | 55820ff9-7b4b-2bce-e063-6394a90a8b43 | 2026-06-30 | Warnings | 451W47IQ8X |
| NebuClear MD Saline | NEBUCLEAR MD SALINE | Blue Echo Care LLC | 55806cb8-cf92-c4e5-e063-6394a90aaa2d | 2026-06-30 | Warnings | 451W47IQ8X |
| NebuClear MD Saline | NEBUCLEAR MD SALINE | Blue Echo Care LLC | 5581d8e5-4105-e9da-e063-6394a90a316e | 2026-06-30 | Warnings | 451W47IQ8X |
| MCAS Support | APIS MELLIFICA, ANTIMONIUM CRUDUM, ASCORBICUM ACIDUM, BOVISTA, CARBOLICUM ACIDUM, CHAMOMILLA, CORTISONE ACETICUM, GINKGO BILOBA, HEPAR SUIS, HISTAMINUM HYDROCHLORICUM, NATRUM MURIATICUM, QUERCETIN, RHUS TOX, SCUTELLARIA LATERIFLORA, STOMACH (SUIS), URTICA URENS | Deseret Biologicals, Inc. | af3d5f8f-6f24-4045-8730-c776ff54bcc4 | 2026-06-24 | Warnings | 451W47IQ8X |
| Midazolam | MIDAZOLAM HYDROCHLORIDE | Onesource Specialty Pharma Limited | 54ed43b2-bad1-4b45-e063-6294a90a793a | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 1666800 1666814 1666823 1666798 W7TTW573JJ |
| Midazolam | MIDAZOLAM | Civica, Inc. | f0c8b6cd-9efc-4344-9212-fbdd3b8e2f9b | 2026-06-19 | Boxed warning, Warnings, Adverse reactions | 1666800 1666798 W7TTW573JJ |
| 0.9% Sodium Chloride Saline Solution | SODIUM CHLORIDE | Yunqi Cosmetics (Shenzhen) Co., Ltd | 546af257-dbd1-11fc-e063-6394a90a8e0a | 2026-06-16 | Warnings | 451W47IQ8X |
| BM BM68 DROPS | ARGENTUM NIT, BARYTA CARB., DULCAMARA, GELSEMIUM, KALI BROM, NAT MUR, CAUSTICUM | BM Private Limited | 53f9c99a-0f20-0358-e063-6394a90af4e0 | 2026-06-15 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.